Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes

Radiotherapy and Oncology

Volumn 95, Issue 2, 2010, Pages 178-184

  Fernandes, Annemarie T ^a   Shen, Jason ^a   Finlay, Jarod ^a   Mitra, Nandita ^a   Evans, Tracey ^a   Stevenson, James ^a   Langer, Corey ^a   Lin, Lilie ^a   Hahn, Stephen ^a   Glatstein, Eli ^a   Rengan, Ramesh ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Definitive radiotherapy; Elective nodal irradiation; Involved field radiotherapy; Mediastinal lymph nodes; Non small cell lung cancer

Indexed keywords

ADULT; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTIVE NODAL IRRADIATION; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; INVOLVED FIELD RADIOTHERAPY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; TREATMENT FAILURE; TREATMENT OUTCOME; CANCER INVASION; CANCER STAGING; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOTHERAPY;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77956628128     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.02.007     Document Type: Article

References (29)

1. Lung Cancer. 10 June 2009. Centers for Disease Control and Prevention. 6 July 2009.
2. Halperin EC, Perez CA, Brady LW. Perez and Brady's principles and practice of radiation oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
3. Le Chevalier T et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991;83:417-23.
4. Saunders M et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet 1997;350:161-5. (Pubitemid 27303621)
5. Perez CA, Stanley K, et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group. Cancer 1980;45:2744-53. (Pubitemid 10063330)
6. Rengan R et al. Improved local control with higher doses of radiation in largevolume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;60:741-7. (Pubitemid 39311753)
7. Belderbos JS, Heemsbergen WD, et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:126-34. (Pubitemid 44175671)
8. Kong FM, Ten Haken RK, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable nonsmall- cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:324-33. (Pubitemid 41317147)
9. Zhao L, West BT, et al. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2007;68:103-10. (Pubitemid 46589842)
10. Graham AN et al. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 1999;117:246-51. (Pubitemid 29068380)
11. Wu J, Ohta Y, et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg 2001;71: 1772-7 [discussion 1777-8]. (Pubitemid 32554396)
12. Gould MK, Kuschner WG, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003;139:879-92.
13. Bueno R et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 2000;70:1826-31. (Pubitemid 32015269)
14. Wagner Jr H et al. Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung. LCSG 881. Chest 1994;106:348S-54S. (Pubitemid 24370973)
15. Lin DY, Psaty BM, et al. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 1998;54:948-63. (Pubitemid 28429289)
16. Mitra N, Heitjan DF. Sensitivity of the hazard ratio to non-ignorable treatment assignment in an observational study. Stat Med 2007;26:1398-414. (Pubitemid 46380849)
17. Cunlift PN, Mann JR, et al. Radiosensitivity in ataxia-telangiectasia. Br J Radiol 1975;48:374-6.
18. Morgan JL, Holcomb TM, et al. Radiation reaction in ataxia telangiectasia. Am J Dis Child 1968;116:557-8.
19. Rosenzweig KE et al. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol 2007;25:5557-61.
20. Kepka L, Bujko K, et al. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3Dconformal radiotherapy (3D-CRT) techniques - a retrospective analysis. Acta Oncol 2008;47:95-103.
21. Yuan S et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 2007;30:239-44. (Pubitemid 46884142)
22. Senan S, Burgers S, et al. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 2002;54:999-1006. (Pubitemid 35299439)
23. Grills IS, Yan D, et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensitymodulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 2003;57:875-90. (Pubitemid 37194316)
24. Fournel P, Robinet G, et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe lyon-saint-etienne d'oncologie thoracique-groupe francais de pneumo-cancerologie NPC 95-01 study. J Clin Oncol 2005;23:5910-7.
25. Curran WJ, Scott CB, et al. Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. ASCO 2003 2003;22:621 [abstract 2499].
26. Aydiner A et al. Third-generation drugs in the chemoradiation of stage III nonsmall cell lung cancer (NSCLC): a meta-analysis of efficacy and toxicity parameters. ASCO 2009 2009 [abstract 7536].
27. Zinner RG, Komaki R, Cox JD, et al. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009;73:119-27.
28. Novello S, Le Chevalier T. Use of chemo-radiotherapy in locally advanced nonsmall cell lung cancer. Eur J Cancer 2002;38:292-9. (Pubitemid 34137003)
29. Schallier D, Bral S, Ilsen B, et al. Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC). J Thorac Oncol 2009;4:728-35.